2020. THE IMPORTANCE OF TARGETED NEXT-GENERATION SEQUENCING USAGE IN CYTOGENETICALLY NORMAL MYELOID MALIGNANCIES: Targeted next-generation sequencing usage in cytogenetically normal myeloid malignancies. Mediterranean Journal of Hematology and Infectious Diseases. 13, 1 (Dec. 2020), e2021013. DOI:https://doi.org/10.4084/mjhid.2021.013.